Home › NDC Lookup › RxCUI directory › RxCUI 545118

Levofloxacin 15 MG/ML Ophthalmic Solution — RxCUI 545118

RxNorm drug concept · Semantic clinical drug
RxCUI 545118 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI545118
Official nameLevofloxacin 15 MG/ML Ophthalmic Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslevofloxacin 1.5 % Ophthalmic Solution
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Levofloxacin Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats serious bacterial infections in adults, such as pneumonia, skin infections, urinary and kidney infections, and prostatitis. It is also used after anthrax exposure and for...
  • What is levofloxacin injection used for?
  • A nurse or clinician gives it as a slow drip into a vein, usually once a day over 60 to 90 minutes. It is never pushed quickly, since that can drop your blood pressure. Drink enoug...
  • Nausea, headache, diarrhea, trouble sleeping, constipation and dizziness are the most common. These are usually manageable, but tell your care team if they bother you.
📖 Read our full Levofloxacin Injection guide →

🕸️ Concept Web — How Levofloxacin 15 MG/ML Ophthalmic Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Levofloxacin 15 MG/ML Ophthalmic Solution RxCUI 545118

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Levofloxacin 82122
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Levofloxacin Ophthalmic Solution 376884
    • Levofloxacin Ophthalmic Product 1163465
    • Ophthalmic Solution 7670
    • Ophthalmic Product 1151135
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Levofloxacin 15 MG/ML 545117

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Levofloxacin 15 MG/ML SCDC · 545117
  • Levofloxacin Ophthalmic Solution SCDF · 376884
  • Levofloxacin Ophthalmic Product SCDG · 1163465

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 545118 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
42571-0168-25 1 BOTTLE in 1 CARTON (42571-168-25) / 5 mL in 1 BOTTLE LEVOFLOXACIN Micro Labs Limited 2019-04-16
54288-0140-01 1 CARTON in 1 CARTON (54288-140-01) / 5 mL in 1 CARTON Levofloxacin BPI LABS LLC 2020-07-13
Observed labelers: BPI LABS LLC (1) · Micro Labs Limited (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.